Cargando…

DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer

Germline pathogenic mutations in BRCA1 increase risk of developing breast cancer. Screening for mutations in BRCA1 frequently identifies sequence variants of unknown pathogenicity and recent work has aimed to develop methods for determining pathogenicity. We previously observed that tumor DNA methyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flower, Kirsty J, Shenker, Natalie S, El-Bahrawy, Mona, Goldgar, David E, Parsons, Michael T, Spurdle, Amanda B, Morris, Joanna R, Brown, Robert, Flanagan, James M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844213/ https://www.ncbi.nlm.nih.gov/pubmed/26727311 http://dx.doi.org/10.1080/15592294.2015.1111504

Ejemplares similares

Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants
por: Vallée, Maxime P., et al.
Publicado: (2016)

Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues
por: Shenker, Natalie S, et al.
Publicado: (2015)

Multifactorial Likelihood Assessment of BRCA1 and BRCA2 Missense Variants Confirms That BRCA1:c.122A>G(p.His41Arg) Is a Pathogenic Mutation
por: Whiley, Phillip J., et al.
Publicado: (2014)

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example
por: Mohammadi, Leila, et al.
Publicado: (2009)

BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2012)

Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients
por: Yoon, Kyong-Ah, et al.
Publicado: (2017)

Classification of VUS and unclassified variants in BRCA1 BRCT repeats by molecular dynamics simulation
por: Sinha, Siddharth, et al.
Publicado: (2020)

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
por: Momozawa, Yukihide, et al.
Publicado: (2022)

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
por: Gómez García, Encarna B, et al.
Publicado: (2009)

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer
por: Cao, Wen-Ming, et al.
Publicado: (2016)

BRCA1 homozygous unclassified variant in a patient with non-Fanconi anemia: A case report
por: Bondavalli, Davide, et al.
Publicado: (2018)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

Dealing With BRCA1/2 Unclassified Variants in a Cancer Genetics Clinic: Does Cosegregation Analysis Help?
por: Zuntini, Roberta, et al.
Publicado: (2018)

Developing pathways to clarify pathogenicity of unclassified variants in Osteogenesis Imperfecta genetic analysis
por: Balasubramanian, Meena, et al.
Publicado: (2019)

Effect of BRCA2 sequence variants predicted to disrupt exonic splice enhancers on BRCA2 transcripts
por: Whiley, Phillip J, et al.
Publicado: (2010)

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes
por: Caleca, Laura, et al.
Publicado: (2019)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
por: Li, Shuai, et al.
Publicado: (2022)

Federated analysis of BRCA1 and BRCA2 variation in a Japanese cohort
por: Casaletto, James, et al.
Publicado: (2022)

Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance
por: Parsons, M, et al.
Publicado: (2012)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Assessing biases of information contained in pedigrees for the classification of BRCA-genetic variants: a study arising from the ENIGMA analytical working group
por: Kerkhofs, C. H. H., et al.
Publicado: (2016)

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
por: O’Mahony, Denise G., et al.
Publicado: (2023)

A Functional Analysis of the Unclassified Pro2767Ser BRCA2 Variant Reveals Its Potential Pathogenicity that Acts by Hampering DNA Binding and Homology-Mediated DNA Repair
por: Esposito, Maria Valeria, et al.
Publicado: (2019)

Unclassifiable Leukaemias
por: Geary, C.
Publicado: (1976)

Unclassified Fevers
Publicado: (1899)

An Unclassified Disease
Publicado: (1893)

Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
por: Lovelock, Paul K, et al.
Publicado: (2007)

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
por: Hakkaart, Christopher, et al.
Publicado: (2022)

An Unclassified Microorganism: Novel Pathogen Candidate Lurking in Human Airways
por: Fukuda, Kazumasa, et al.
Publicado: (2014)

Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients
por: Lee, Eunjung, et al.
Publicado: (2008)

Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients
por: Grasel, Rebeca Silveira, et al.
Publicado: (2020)

Estimation of probabilities in favour of pathogenicity for missense substitutions for use in clinical evaluation of mismatch repair gene variants
por: Thompson, B, et al.
Publicado: (2012)

Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers
por: Walker, Logan C, et al.
Publicado: (2017)

Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
por: Shenker, N, et al.
Publicado: (2012)

Unclassified fluent variants of primary progressive aphasia: distinction from semantic and logopenic variants
por: Watanabe, Hiroyuki, et al.
Publicado: (2022)

BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding
por: Burke, Leslie J., et al.
Publicado: (2018)

Denaturing high-performance liquid chromatography (DHPLC) as a fast tool to screen a control population for the occurrence of unclassified variants (UV) in the BRCA1 gene
por: Arnold, N, et al.
Publicado: (2000)

Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers
por: Walker, Logan C., et al.
Publicado: (2018)

BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression
por: Waddell, Nic, et al.
Publicado: (2008)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
por: Osman, K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u612jfk1ltrjr90v83tv9htckj